This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

2 Deals to Watch: Beer With a Shot of Derivatives

Stocks in this article: NYX ICE BUD NDAQ T

NEW YORK ( TheStreet) -- To get regulatory approval for their $9 billion merger announced in February, NYSE Euronext (NYX) and Deutsche Boerse will open up their combined derivatives businesses to rivals and divest other units.

In October, European Union competition authorities added to objections of the merger, which values NYSE Euronext at $36.09 a share and received shareholder approval in July. The New York-based exchange has traded 25% below the merger price because of increasing scrutiny about the deal, falling trading volumes fell and global economic fears. On news of the derivatives remedy, NYSE shares rose over 5% to $28 a share in pre-market trading.

The merger was subjected to a second review by the European Union in August because it was seen to lead to increasing concentration in derivatives trading and clearing, potentially harming competitiveness. When announcing a second review, EU Competition Commissioner Joaquin Almunia said, "The proposed merger would remove a strong competitor from the market and would give the merged company by far the leading position in derivatives trading in Europe."

In October, the European Union further highlighted the combined company's dominance in derivatives trading and clearing as its biggest competition concern.

The combination of the two companies would create Europe's largest equity and derivatives exchange. The NYSE's roots trace back to the 18th century, while stock markets under the Deutsche Boerse have a history that the company traces to the 16th century, according to its website.

Concerns about the merger by regulatory authorities hinge on whether competitors would be able to access the clearinghouse to process derivatives trades that would come as a result of the merger. Clearing, a key piece of the 2010 Dodd Frank Act reform derivative of markets, lessens the credit risks of trading counterparts to the wider financial system -- and is seen to be a new profit center for exchanges.

Currently, NYSE Euronext owns derivatives trading business NYSE Liffe and Deutsche Boerse is owner of Eurex, a similar platform. Both provide for trading of derivatives based on interest rates, bonds, equities, indices, commodities and swaps, as well as clearing functions.

Today's news signals that both exchanges are going to allow rivals to access their clearinghouses, in a move to stem anti-competitive concerns. That move, along with a sale of equity derivatives units is seen by NYSE and Deutsche Boerse as the cure. "Eliminating the existing overlap in European single equity derivatives and ensures continued competition in European interest rate and equity index derivatives," both companies said in a statement Friday.

The $9 billion deal between Deutsche Boerse and the leading U.S. stock exchange announced in February isn't the only deal that's come under regulatory scrutiny. In August, the U.S. Department of Justice filed an antitrust lawsuit against AT&T's (T)proposed $39 billion merger with T-Mobile.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs